Table 1.
Characteristics of Study Participants in Women’s Study (Qualitative) and FASTLANE-II (Quantitative)
| Characteristic | Women’s Study n=18 n (%) |
FASTLANE-II n=154 n (%) |
|
|---|---|---|---|
| Mean age (range), years | 41.2 (26–57) | 36.6 (18–63) | |
| Age 18–44, years | 12 (66.7) | 121 (78.6) | |
| Age 45+, years | 6 (33.3) | 33 (21.4) | |
| Race/Ethnicity | White | 7 (38.8) | 59 (38.3) |
| African American | 6 (33.3) | 39 (25.3) | |
| Latina | 4 (22.2) | 33 (21.4) | |
| Asian/Other | 1 (5.5) | 23 (14.9) | |
| Types of PV | Lifetime physical PV only | 5 (27.8) | 77 (51.7) |
| Lifetime sexual PV only | 1 (5.5) | 14 (9.4) | |
| Lifetime physical & sexual PV | 12 (66.7) | 58 (38.9) | |
| Currently in an abusive relationship (past 2 months) | 3 (16.7) | 48 (31.1) | |
| Current Drug use* | MA only | 8 (44) | 2 (1.4) |
| MA and marijuana | 1 (5.5) | 111 (75.0) | |
| MA and prescription drugs** | 1 (5.5) | 1 (0.7) | |
| MA, marijuana and prescription drugs | 1 (5.5) | 34 (23.0) | |
| Lifetime Drug use | MA | 18 (100) | 154 (100) |
| Marijuana | 4 (22.2) | 151 (98.1) | |
| Cocaine | 4 (22.2) | 112 (72.7) | |
| Heroin | 3 (16.7) | 46 (29.9) | |
| Prescription drugs** | 2 (11.1) | 70 (47.0) | |
PV, partner violence; MA, methamphetamine
*
Drug categories are mutually exclusive. Drug use timeframe for Women’s Study included previous two months and timeframe for FASTLANE-II included one month prior.
**
Prescription drugs refer to any non-medical use of prescription drugs, which includes tranquilizers, barbiturates, ketamine and gamma-Hydroxybutyric acid (GHB).